In this article, we will look at the 8 Best Small Cap US Stocks to Buy.
Small-cap US stocks are getting another look as investors search for opportunities beyond the mega-cap names that dominated much of the market’s recent advance. The case is not just that smaller companies have lagged. It is that earnings expectations, valuations, and market breadth are starting to look more supportive at the same time. Franklin Templeton says “both small-cap quality and value are poised for meaningful rebounds in 2026” and adds that “2026 could be the year that small-caps reassert themselves.”
The broader institutional commentary points in the same direction. AllianceBernstein says “Earnings growth, for example, is expected to outstrip those for large companies in 2026,” while “small-cap earnings could be widely underestimated by the market.” In summary, the opportunity is not simply that small caps look cheaper. It is possible that expectations may still be too low if earnings visibility keeps improving. T. Rowe Price makes a similar point, arguing that the small-cap rebound has not been driven by sentiment alone because “fundamentals also have turned.”
Against this backdrop, small-cap US stocks deserve a closer look, especially those with improving earnings trends, manageable leverage, analyst support, and exposure to themes where demand is starting to broaden beyond large-cap leaders. With that in mind, let’s take a look at the 8 Best Small Cap US Stocks to Buy.
Pixabay/Public Domain
Our Methodology
We used the Finviz screener to identify US stocks that have a market capitalization of $300 million to $2 billion and are viewed favorably by analysts. We then limited our final selection to companies that have recently reported noteworthy developments likely to impact investor sentiment. These stocks are also popular among analysts and elite hedge funds.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 498.7% since May 2014, beating its benchmark by 303 percentage points (see more details here).
8. Sable Offshore Corp. (NYSE:SOC)
On May 6, 2026, Sable Offshore Corp. (NYSE:SOC) reported Q1 EPS of ($1.37), versus the consensus estimate of (52c). Revenue totaled $1.27M, versus the consensus estimate of $8.05M. The company said it continues progressing discussions tied to the refinancing of its Senior Secured Term Loan, which it expects to complete during Q2 2026.
On April 22, 2026, Jefferies lowered the firm’s price target on Sable Offshore Corp. to $24 from $30 while maintaining a Buy rating following the company’s operational and financial update and a fireside chat hosted with CEO Jim Flores and CFO Greg Patrinely.
Earlier in April, Sable Offshore Corp. provided a broader corporate update covering operational, legal, and financial developments. The company said the previously announced restart of oil transportation through Segments 324 and 325 of the Santa Ynez Pipeline System was completed in compliance with applicable safety standards under its pipeline integrity management program. Sable said 40 wells currently operating across Platform Harmony and Platform Heritage are producing an average of 750 gross barrels of oil per day per well. Once all 74 production wells are online, the company expects average production to reach approximately 700 gross barrels per day per well. Platform Hondo is expected to begin operations in June 2026 with an estimated fully ramped production rate of approximately 10,000 gross barrels of oil per day.
The company also said capital spending across its assets is expected to total approximately $180M from April through December 2026 as it focuses on facility upgrades, maintenance spending, and production optimization initiatives. Sable added that it is in discussions with both banking partners and the U.S. government regarding potential federal credit support tied to the planned refinancing. Concurrent with the refinancing, the company intends to implement a commodity hedging program focused on protecting cash flow while preserving upside exposure. To date, Sable Offshore Corp. said it has sold more than 7.0M shares through its at-the-market equity program, generating approximately $95M in gross proceeds. The company also noted that the U.S. Department of Justice has moved to terminate or modify an existing Consent Decree related to litigation in California federal court, with a hearing scheduled for June 1. Sable is not a party to the litigation but said it is participating in a briefing tied to the proposed changes.
Sable Offshore Corp. operates as an independent oil and gas company with offshore California production platforms.
7. Universal Technical Institute, Inc. (NYSE:UTI)
On May 7, 2026, Barrington analyst Alexander Paris raised the firm’s price target on Universal Technical Institute, Inc. (NYSE:UTI) to $42 from $36 while maintaining an Outperform rating. The firm said the company’s fiscal Q2 results came in above expectations and added that while near-term investments are expected to pressure earnings in fiscal 2026 and 2027, Universal Technical should continue seeing strong enrollment and earnings growth into fiscal 2028 and 2029.
Rosenblatt analyst Steve Frankel also raised the firm’s price target on Universal Technical Institute, Inc. to $45 from $36 while maintaining a Buy rating. The firm said margins remain pressured by investments tied to new campuses and program expansions, though management continues making moves that position the company for steady growth and future margin expansion following what Rosenblatt described as another solid quarter of execution.
On May 6, 2026, Universal Technical Institute, Inc. reported Q2 EPS of 1c. Revenue totaled $221.4M, versus the consensus estimate of $221.16M. CEO Jerome Grant said first-half performance continued to meet and exceed expectations, supported by sustained demand across both operating divisions and continued progress on the company’s North Star initiatives. Grant also said the company sees expanding opportunity as the labor market undergoes what management described as a generational shift, with artificial intelligence increasing demand for skilled workers needed to support data centers, energy systems, advanced manufacturing, and healthcare infrastructure. Grant added that the company believes actions being taken in fiscal 2026 should support near-term growth while creating additional enrollment and earnings opportunities in fiscal 2027 and beyond.
Universal Technical Institute, Inc. provides transportation, skilled trades, and healthcare education programs in the United States through its UTI and Concorde segments.
6. FIGS, Inc. (NYSE:FIGS)
On May 7, 2026, FIGS, Inc. (NYSE:FIGS) reported Q1 EPS of 3c, versus the consensus estimate of 2c. Revenue totaled $159.9M, versus the consensus estimate of $153.14M. Active customers as of March 31 increased 12.2% year over year to 3.0M, while net revenues per active customer rose 5.8% year over year to $220. The company said its outperformance during the first quarter reflected continued momentum from 2025, driven by growth in both its active customer base and repeat purchasing trends. FIGS added that the quarter also demonstrated the operating leverage within its business model, while management believes its product, brand, and community strategies, along with broader healthcare industry tailwinds, position the company for continued growth.
FIGS, Inc. said it expects 2026 revenue growth of 14%-16% compared to 2025 and an adjusted EBITDA margin of 13.0%-13.2%. The company added that stronger first-quarter performance increased confidence in its full-year outlook, including expectations for revenue growth in the low-20% range during Q2, supported by trends in customer growth, average order value, and purchase frequency. Management also said the improved profitability outlook reflects both operational execution and continued investment discipline despite elevated freight surcharge costs.
On April 22, 2026, Roth Capital analyst Matt Koranda raised the firm’s price target on FIGS, Inc. to $18 from $15.50 while maintaining a Buy rating ahead of Q1 results. The firm said it remained constructive on the company and expected another solid quarter driven by strong demand and improving operating efficiency, though it also acknowledged investor sensitivity around valuation levels.
FIGS, Inc., through its subsidiary FIGS Canada, operates as a direct-to-consumer healthcare apparel and lifestyle company.
5. Pediatrix Medical Group, Inc. (NYSE:MD)
On May 5, 2026, Pediatrix Medical Group, Inc. (NYSE:MD) reported Q1 adjusted EPS of 44c, versus the consensus estimate of 38c. Revenue totaled $476M, versus the consensus estimate of $465.82M. Same-unit revenue from net reimbursement-related factors increased 4.4% year over year. CEO Mark Ordan said first-quarter operating results exceeded expectations, driven by top-line growth, while adding that the company’s priorities for 2026 remain centered on supporting hospital partners through quality-focused care delivery. Ordan also said Pediatrix believes its strong cash flow generation and balance sheet position the company to pursue additional opportunities moving forward. Pediatrix Medical Group, Inc. reaffirmed its FY26 adjusted EBITDA outlook of $280M-$300M.
On April 20, 2026, Jefferies analyst Jack Slevin raised the firm’s price target on Pediatrix Medical Group, Inc. to $27 from $24 while maintaining a Buy rating. The firm said recent underperformance across healthcare services stocks reflected investor concerns tied to Q1 patient volumes, though Jefferies questioned whether consensus expectations fully accounted for weather-related disruptions caused by winter storms in Southern and East Coast markets.
Meanwhile, Truist raised the firm’s price target on Pediatrix Medical Group, Inc. to $23 from $21 while maintaining a Hold rating as part of a broader preview of healthcare services earnings. Truist said it remains constructive on the sector given strong demand trends, supportive reimbursement conditions, defensive characteristics, and continued benefits tied to AI, automation, and connectivity initiatives.
Pediatrix Medical Group, Inc. provides newborn, maternal-fetal, and pediatric subspecialty healthcare services in the United States.
4. Walker & Dunlop, Inc. (NYSE:WD)
On May 8, 2026, Keefe Bruyette raised the firm’s price target on Walker & Dunlop, Inc. to $67 from $65 while maintaining an Outperform rating on the shares.
A day earlier, Walker & Dunlop, Inc. reported Q1 adjusted core EPS of $1.02, versus the consensus estimate of 54c. Revenue totaled $301.3M, versus the consensus estimate of $269.07M. Chairman and CEO Willy Walker said the company’s strong first-quarter transaction volumes and earnings reflected the strength of the W&D team, brand, and position within commercial real estate capital markets. Walker added that robust financing activity drove strong quarterly transaction fees, which, together with recurring servicing and asset management fees, supported solid quarterly earnings as the company pursues its annual and long-term financial targets.
On April 23, 2026, Stephens initiated coverage of Walker & Dunlop, Inc. with an Overweight rating and a $69 price target. The firm said it favors real estate finance companies with lower cyclicality and the ability to generate consistent earnings growth across market cycles, adding that Walker & Dunlop’s servicing and asset management segment contributes to a more balanced business model. Stephens also described the stock’s valuation discount as an attractive entry point.
Walker & Dunlop, Inc., through its subsidiaries, originates, sells, and services multifamily and commercial real estate financing products and services in the United States.
3. Innovex International, Inc. (NYSE:INVX)
On May 6, 2026, Citi initiated coverage of Innovex International, Inc. (NYSE:INVX) with a Buy rating and a $35 price target. The firm said it views the company favorably due to its lower cyclicality and robust free cash flow conversion relative to oilfield service peers, while also believing Innovex can continue gaining market share across its end markets.
On May 4, 2026, Innovex International, Inc. reported Q1 revenue of $239M, down 1% year over year. CEO Adam Anderson said the company delivered a strong start to 2026, with both revenue and adjusted EBITDA exceeding the high end of guidance. Anderson said results benefited from operational execution, new product launches, cross-selling activity, favorable product mix, and earlier-than-expected gains from the exit of the legacy Eldridge facility. Anderson added that the quarter reinforced management’s view that the company’s subsea businesses can generate margins above 20% under its capital-light operating model.
The company also said it completed the acquisition of DIS during the quarter, adding production technologies that complement its portfolio and strengthen its offshore U.S. market position. Anderson added that Innovex continues gaining share through innovation, service quality, and the scale of its integrated platform, which management believes supports durable and profitable growth.
Innovex International, Inc. expects Q2 revenue of $235M-$245M and adjusted EBITDA of $43M-$48M.
Innovex International, Inc. designs, manufactures, sells, and rents engineered products for the oil and natural gas industry globally.
2. Adient plc (NYSE:ADNT)
On May 7, 2026, Deutsche Bank raised the firm’s price target on Adient plc (NYSE:ADNT) to $31 from $30 while maintaining a Buy rating on the shares. Stifel analyst Nathan Jones also raised the firm’s price target on Adient plc (NYSE:ADNT) to $28 from $26 and kept a Buy rating.
On May 6, 2026, Adient plc (NYSE:ADNT) reported Q2 adjusted EPS of 52c, versus the consensus estimate of 44c. Revenue totaled $3.87B, versus the consensus estimate of $3.63B. The company said it delivered solid quarterly results while continuing to execute with discipline in what it described as a dynamic operating environment. Management added that teams remained focused on supporting customers, maintaining operational execution, and driving growth initiatives.
Adient plc (NYSE:ADNT) raised its FY26 revenue outlook to $14.8B from $14.6B, versus the consensus estimate of $14.63B. The company also raised its FY26 adjusted EBITDA outlook to $885M from $880M and increased its free cash flow outlook to $130M from $125M, while maintaining its capital expenditures forecast of $300M. The company said its stronger first-half execution and ability to navigate external headwinds supported the decision to raise full-year guidance. Management also said Adient continues to maintain a strong balance sheet and liquidity position as it focuses on operational execution, regional growth, and margin expansion.
Adient plc (NYSE:ADNT) designs, develops, manufactures, and markets seating systems and components for passenger cars, commercial vehicles, and light trucks.
1. Spectrum Brands Holdings, Inc. (NYSE:SPB)
On May 8, 2026, Canaccord raised the firm’s price target on Spectrum Brands Holdings, Inc. (NYSE:SPB) to $100 from $94 and kept a Buy rating on the shares. The firm said Spectrum Brands delivered solid Q2 results, with sales coming in about 5% above consensus, while adjusted EBITDA and adjusted EPS were both roughly 23% ahead of expectations, led by strength in the Home & Garden segment.
A day earlier, Spectrum Brands Holdings, Inc. reported Q2 adjusted EPS of $1.25, versus the consensus estimate of $1.06. Revenue totaled $708.9M, versus the consensus estimate of $677.4M. Chairman and CEO David Maura said the company returned to top-line growth for the first time since the first quarter of fiscal 2025, supported by continued outperformance from key brands in the Global Pet Care and Home & Garden businesses, driven by innovation and distribution gains. Maura added that while Home & Personal Care sales declined, adjusted EBITDA improved due to actions taken over the past year, which management believes reinforces the effectiveness of its strategic initiatives.
Spectrum Brands Holdings, Inc. said it now expects fiscal 2026 adjusted EBITDA growth in the low-to-mid single-digit range while maintaining its outlook for flat to low single-digit net sales growth. The company also said adjusted free cash flow is expected to equal approximately 50% of adjusted EBITDA.
Spectrum Brands Holdings, Inc. operates as a branded consumer products and home essentials company across North America, Europe, the Middle East, Africa, Latin America, and Asia-Pacific.
READ NEXT: 10 AI Stocks with Potential to Rise 1000 Percent and 10 Best AI Pick-and-Shovel Stocks to Buy
